Medicine and Dentistry
Congenital Hyperinsulinism
100%
Cells
68%
Patient
41%
Hyperinsulinism
37%
Diseases
33%
Hypoglycemia
32%
Adenosine Triphosphate Sensitive Potassium Channel
30%
Gene
29%
Adenosine Triphosphate
26%
Insulin Release
21%
Glucose
20%
Insulin
18%
Potassium Channel
16%
Therapeutic Procedure
16%
Child
15%
Childhood
14%
Analysis
13%
Cell Line
13%
Human Embryonic Stem Cell
13%
Introspection
12%
Human Insulin
12%
Clinical Management
12%
In Vitro
11%
Tissues
11%
Development
10%
Comprehension
10%
Diabetes Mellitus
10%
Beta Cell
10%
Pathophysiology
9%
Kir6.2
9%
Stem Cell
9%
Ion Channel
8%
Sulfonylurea Receptor 1
7%
Pancreatectomy
7%
Etiology
7%
Hyperinsulinemic Hypoglycemia
7%
Diazoxide
7%
Human Cell
7%
Diabetes
6%
Pancreatic Islet
6%
Lesion
6%
Gene Deletion
6%
Kidney Tubule Disorder
6%
Adenoma
6%
Feeding Difficulty
6%
Vineland Adaptive Behavior Scale
6%
Cell Differentiation
6%
Gene Mutation
6%
Syndrome
6%
Endocrine Disease
6%
Biochemistry, Genetics and Molecular Biology
Congenital Hyperinsulinism
70%
Infancy
63%
ATP-Sensitive Potassium Channel
51%
Insulin Release
46%
Nested Gene
39%
Insulin
38%
Glucose
37%
Potassium Channels
28%
Mutation
27%
Genetics
21%
ABCC8
18%
Potassium Channel
18%
ATP-sensitive Potassium Channel
17%
Diazoxide
16%
Sulfonylurea Receptor
15%
Childhood
15%
Introspection
13%
Comprehension
13%
Kir6.2
12%
Gene Deletion
12%
Protein
11%
Development
10%
Rat
10%
Gene Mutation
8%
Mosaicism
8%
Phenotype
8%
PAX4
8%
Cell Culture
8%
Metabolomics
8%
Adenosine Triphosphate
7%
Transcription Factor PDX 1
7%
In Vitro Study
7%
Stimulus Secretion Coupling
7%
Regulatory Mechanism
6%
Somatostatin Cell
6%
Beckwith-Wiedemann Syndrome
6%
Embryonic Stem Cell
6%
Adaptive Behavior
6%
Binding Protein
6%
Messenger RNA
6%
Synthesis
6%
Rodent
6%
Modulation
6%
Adenosine
6%
Chromosome 11p
6%
Cell Lineage
6%
Cellular Differentiation
6%
Independent Pathway
6%
Tolbutamide
5%
Patch Clamp
5%
